RE: who is controlling Novacyt ?6 Sep 2022 17:54
HarChris,
I feel the fact that there are no II's bar Biosynex above 3% holding, and that there are but 70.63 million shares in issue, makes this share more unstable than many.
Despite what McCarthy previously previously stated at Investor Meet, Investor Question 4, -
"institutional investors, - yes it’s desirable, it’s something I think the strategy will attract, So part of the strategy - giving all future investors more certainty about where we are going to invest our money how big a business we think we can grow, - our right to succeed in the chosen areas we compete, - that’s part of building the strategy and the story and I think and hope it will attract institutional investors and reward existing shareholders, that’s clearly a priority." (Investor Meet Investor Question 4).
This was pure eyewash. The company don't want any truck with II's.